New Clinical Trial Underway For Meniere’s Disease
Sound Pharmaceuticals (SPI) is pleased to announce that it has completed enrollment on its first Meniere’s disease (MD) clinical trial. MD is a neurotologic disease that involves episodic vertigo, fluctuating sensorineural hearing loss, and intermittent or constant tinnitus, and is thought to be due to a swelling or inflammation of the inner ear. Patients with…